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two scenarios defined by different tissue parameter values 
(α/β)x representing high and low radio-sensitivity. We 
systematically compared RBE predictions as a function of 
(α/β)x and proton linear energy transfer (LET) values in a 
spread-out Bragg peak (SOBP) in water and analysed results 
on patient-CT anatomy for cranial irradiation in terms of 
absorbed dose-to-water, dose-averaged LET (LETD), RBE-
weighted dose-to-water and biological range shift 
distributions.  
Results: Different levels of agreement depending on (α/β)x 
and LET values were found in the systematic comparison of 
RBE predictions. The SOBP study emphasizes a variation of 
LETD and RBE not only as a function of depth but also of 
lateral distance from the central beam axis. Applying the 
different models to cranial treatment plans we observe 
consistent discrepancies from the values obtained for a 
constant RBE of 1.1 when using the variable RBE scheme in 
tissues with low (α/β)x, regardless of the model. An example 
is reported in figure 1. Biological range shifts of (0.6-2.4) mm 
(high (α/β)x) and (3.0-5.4) mm (low (α/β)x) were found in the 
fall-off analysis of individual profiles of RBE-weighted 
fraction dose along the beam penetration depth. 
Conclusions: Although more experimental evidence is 
required to validate the accuracy of the investigated models, 
their consistent trend suggests that their main RBE 
dependencies should be included in treatment planning 
systems. Evaluation of the impact of a variable RBE scheme 
on the plan optimized using a constant RBE would thus be 
enabled, constituting a first step towards a more robust 
choice of biological dose delivery in proton therapy. 
 
Keywords: Proton therapy, RBE-weighted dose, Monte Carlo 
 
We acknowledge funding from BMBF (SPARTA), DFG (KFG 
Schwerionentherapie 214 and MAP Cluster of Excellence) and 
EU (ENVISION and Erasmus Exchange Program).  
 
References: 
[1] Carabe-Fernandez, A. et al., Int. J. Rad. Biol. 83, 27-39 
(2007)  
[2] Wedenberg, M. et al., Ancta Oncol. 52, 580-88 (2013) 
[3] Elsaesser, T. et al., Int. J. Rad. Oncol. 78(4), 1177-83 
(2010) 
[4] Bauer, J. et al., Phys. Med. Biol. 59, 4635-59 (2014) 
[5] Mairani, A. et al., Phys. Med. Biol. 58, 2471-90 (2013) 
 
 
 
Biological dose calculated using the constant factor of 1.1 
(left) or two different radio-biological models [2,3,5] for low 
(α/β)x, overlaid on the treatment planning CT image; Contour 
outlines the physical target volume.  
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Radiotherapy has proven efficacy to inactivate cancer stem 
cells and is a highly personalized treatment modality, 
tailoring treatment plans for each individual patient based on 
precise anatomical information on tumor size and location as 
well as on normal tissues in the irradiated volume. Models 
based on clinical data, radiobiology and radiation physics are 
routinely used in radiotherapy for generating individualized 
space-resoluted radiation dose distributions, as well as for 
assessment of tumor control probability- vs. normal tissue 
complication-models. Tremendous improvement in high-
precision radiation delivery and planning technology has been 
achieved during the past decades and rapidly been translated 
into clinical practice. 
The new frontier in radiation oncology-related research is 
now to bring together advances in tumor and molecular 
biology with the full potential of high-precision radiation 
technology. Examples of these developments include the 
discovery and assessment of biomarkers specific for 
radiotherapy, the combination of radiotherapy with 
molecular targeted drugs, and the individualization of 
treatment planning by biological imaging. Individualized 
radiotherapy in the future will integrate biological 
information on the specific tumor and on surrounding normal 
tissues in the treatment strategy of patients. Novel 
predictive and prognostic markers demonstrate high potential 
for advancing personalized radiation oncology in preclinical 
and clinical-translational studies. So far this applies for 
stratified selection of total dose, however, in the future also 
personalized dose-distribution and fractionation parameters 
as well for the combined therapies of radiation with specific 
drugs might become predictable by biomarkers. A specific 
feature of personalized radiation oncology is that already 
broad biological stratification of patients has the potential to 
remarkable advance individualization of therapy as this 
information adds a power-function to the fully anatomically-
personalized dose-distributions clinically achieved today. 
This talk will review preclinical and clinical examples of 
potential strategies to increase cure rates by adding a biology 
dimension (e.g. predictive/ prognostic markers) to 
personalized radiation oncology. 
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Purpose:  Several studies indicate the potential dosimetric 
benefit of combining IMRT and VMAT in a hybrid approach [1, 
2].  This study evaluates the accuracy of in-vivo portal 
dosimetry for a variety of hybrid IMRT and VMAT plans for 
radiotherapy of the prostate. 
Materials/methods:  Hybrid IMRT and VMAT plans were 
retrospectively constructed for five prostate patients.  Three 
PTVs were used, namely PTV74Gy, PTV71Gy and PTV60Gy.  
For each patient, seven 6MV plans were created: a conformal 
VMAT arc, a VMAT arc with limited modulation, and five 
hybrid IMRT / VMAT arcs, with 0%, 25%, 50%, 75% and 100% 
IMRT respectively, with 0% corresponding to normal VMAT 
and 100% corresponding to 11-beam IMRT.  All plans consisted 
of a single anticlockwise arc with 111 segments ranging in 
gantry angle from 110° to 250°.  The hybrid plans were 
created by grouping the control points into 20° groups, and 
then selecting the groups with the most complex intensity 
maps for sequencing as IMRT, with the remaining groups 
sequenced for VMAT. 
Predicted integrated portal images were created for all plans 
as delivered to a water-equivalent phantom [3].  The plans 
were then delivered to the phantom as a single beam 
sequence using an Elekta Synergy accelerator with Agility 
head and integrated images were measured using an Elekta 
iViewGT portal imager.  Predicted and measured images 
were compared in terms of mean gamma and percentage 
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gamma less than unity at the 3% / 3 mm level.  The dose at 
the treatment isocentre was also measured using a Farmer 
ionisation chamber and treatment times were recorded. 
Results:  A typical treatment plan is shown in Figure 1, 
together with the predicted portal image, the measured 
portal image and the gamma comparison.  Table 1 
summarises the results for all plans and patients.  Predicted 
images show particularly good agreement for conformal and 
limited-modulation VMAT plans due to the simplicity of the 
plans, but the agreement is also acceptable for the 
considerably more complex hybrid plans. 
 
 
 
Conclusions:  Portal dosimetry can be carried out accurately 
and effectively for hybrid IMRT and VMAT treatments.  The 
25% IMRT hybrid plan is of most interest practically as it 
offers improved dosimetry without taking a long time to 
deliver, and this plan shows acceptable accuracy of 
verification with portal dosimetry. 
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Purpose: This work aims to present a flexible 
computational model for the calculation of the lateral 
deflection of a pencil proton beam, and the 
preliminary results of its implementation in a 
Treatment Planning System (TPS) instead of the 
currently used Double Gaussian approximation (DGA) in 
water. 
First evidences show that the model has better accuracy 
with fast computation time in water; it is reliable for any 
depth and for every kind of media and mixture, since 
energy loss effects by the primary process are fully taken 
into account. 
Methods: Challenging issues in TPS for hadrontherapy 
are the accurate calculation of dose distribution, the 
reduction in memory space required to store the dose 
kernel of individual pencil beams and the shortening of 
computation time for dose optimization and calculation. 
In this framework, prediction of lateral dose 
distributions is a topic of great interest because, 
currently, a DGA [1], [2] is typically used as 
approximation; although other parameterizations are also 
available [3], [4], [5]. The best accuracy in this kind of 
calculations can be obtained by Monte Carlo (MC) 
methods [6], but at the expense of a too long computing 
time. 
As alternative, we propose a flexible model based on the 
full Molière theory for Coulomb multiple scattering [7]. 
The use of the original equations of the theory allows to 
remove any free parameter for the electromagnetic 
interaction with the advantage of full accuracy with a 
reasonable increase in the computing time. The 
contribution of the nuclear interactions are also fully 
taken into account with a two-parameters fit, on FLUKA 
simulation [8],[9]; this part is added to the 
electromagnetic core with a proper weight [10]. 
Model is currently under testing in a particle therapy 
extension of CERR - A Computational Environment for 
Radiotherapy Research [11], [12] TPS, in order to compare 
the results with the actual dose prediction in water. 
Results and Conclusions: The model has been first 
compared to MC predictions for protons in water, for 
different depths and therapeutic energies, and also 
with some experimental data from Heidelberg Ion-Beam 
Therapy Center (HIT), generally showing very good 
agreement. 
The comparison of the CERR dose distribution 
calculated using DGA with the one predicted by the 
computational model is shown in Figure 1 together with 
FLUKA MC prediction. 
The DGA has a lateral cutoff distance from the central ray 
that is used to determine the points that do not require 
dose calculation that has been set at maximum possible 
value 4 (in multiples of the gaussian lateral extend at the 
end of the decay area). 
 
